Lundbeck says cancer drug approved in Canada
COPENHAGEN Aug 28 (Reuters) - Danish pharmaceutical group Lundbeck said on Tuesday it had received approval from Health Canada for its cancer treatment Treanda which is used to treat two common types of cancer including lymphocytic leukaemia.
Lundbeck said the move would substantially strengthen the group's growth outlook, but kept its full-year guidance intact.
It said it expected Treanda would be available to physicians and patients in Canada during September.
(Reporting by Mette Fraende; Editing by Dan Lalor)
- Tweet this
- Share this
- Digg this
- Fears for tough penalties grow as India cleans up business
- India warns Pakistan of more pain in Kashmir fighting
- Giving pricey hepatitis drug to prisoners may be financially wise
- No fear of deflation: Indian consumers respond to softer oil, food prices
- Yahoo CEO Marissa Mayer parries activist investor attacks